Reply  by Nedeau, April Estelle & Schermerhorn, Marc L.
LETTERS TO THE EDITORRegarding “Endovascular vs open repair for ruptured
abdominal aortic aneurysm”
To paraphrase the conclusion of the recent paper by Nedeau et
al, they boldly state that “Given the mounting evidence for survival
advantage of rEVAR, RCTs of ruptured AAA may be unnecessary.
Thus, we recommend rEVAR as the standard of care,”1 which
reminds us of Horton’s painful caveat toward surgical research.2
Of note, the above notion was based on a retrospective analysis of
notmore than 74 patients (only 26% received ruptured endovascular
aneurysm repair [rEVAR]), whereas the authors suggested to ignore
conﬂicting randomized evidence because of its ‘small sample size.’1
What is this ‘mounting evidence’ of rEVAR superiority apart
from selective observations? First, the alleged mounting evidence
is the conclusion by analogy with elective aortic repair, where
EVAR reduced operative mortality signiﬁcantly in randomized
trials. What is easily forgotten, however, is that this applies only to
aneurysms suitable for EVAR. For ruptured aneurysms at least,
endovascular suitability was shown to be a strong predictor of
outcome,which is independent of the actual type of repair3 implying
relevant patient selection bias across nonrandomized series.4
Second, the alleged mounting evidence is the synopsis of
meta-analyses of open and endovascular ruptured abdominal aortic
aneurysm (rAAA) repair, respectively. Admittedly, these data seem
to demonstrate that perioperative mortality could be halved by use
of rEVAR (40% vs 20%).3 However, such a comparison essentially
means comparing the results of highly specialized centers of excel-
lence, treating carefully selected patients with the results of the
average vascular emergency service, which is left with increasingly
complex patients (eg, juxtarenal rAAA).
Unfortunately, results of open rAAA repair that do not ﬁt into
this ‘mounting evidence’ are easily ignored. For instance,we have re-
ported the surgical outcomes of 248 patients with rAAA over the
same period as the present study. Overall surgical 30-day mortality
was as low as 15.3%, although this consecutive series included all
comers including those with juxta- and suprarenal aneurysms, and
almost all underwent open repair (97%).3 Even among octogenar-
ians, surgical mortality was at 27% and, thus, below the reported
mortality of the entire present series, which was at 41% (30/74).1,5
Should we conclude that open repair be recommended for
every rAAA? Certainly not. Such a recommendation would be as
baseless as the above. rEVAR is an excellent option for properly
selected patients and centers. The point is the alleged ‘mounting
evidence’ is far from consistent.
Properly designed and powered randomized controlled trials
are needed more than ever because in the absence of compelling
evidence, costs associated with provision of around-the-clock
emergency endovascular infrastructure and expertise are difﬁcult
to justify. Moreover, many patients will continue to need open
repair (even in the current study, more than 53% of rAAA were
treated by open repair after introduction of the endovascular
protocol); therefore, open surgical competence must not be lost.
If anything, there is mounting evidence that similar results can
be reached by any method of repair if performed competently. To
improve overall results, comprehensive emergency management
should focus on an effective rescue chain, adequate imaging, proper
patient selection, delayed volume resuscitation, and fast control of
aortic bleeding.3 For this will beneﬁt all patients, and not only
a selected subset, aswill adequate surgicaland endovascular training.
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Reply
We recommend an “EVAR-ﬁrst approach” as the new stan-
dard of care in the treatment of ruptured abdominal aortic aneu-
rysms (rAAA) as outlined in our article “Endovascular vs open
repair for ruptured abdominal aortic aneurysm.” A multidisci-
plinary protocol, with endovascular surgical staff and equipment
availability is emphasized, to reduce perioperative mortality which
was 15.7% and 49% for ruptured endovascular aneurysm repair
(rEVAR) and open surgical repair (OSR), respectively. Overall
rAAA mortality, regardless of repair type, was 54% pre-EVAR
and 27% in the post-EVAR era. We found similar mortality
changes over time with administrative data from the Nationwide
Inpatient Sample database in which overall ruptured AAA repair
mortality decreased from 44.3% pre-EVAR to 39.9% post-EVAR
(open repair, 44.3%; EVAR, 32.4%) and more recently with Medi-
care data (overall mortality 44% in 1995 to 36% in 2008).1,2 We
recognize that our data are observational, yet our institutional
data are similar to a large number of single-center, multicenter,
nationwide database studies and meta-analyses that report similar
beneﬁt of rEVAR over OSR. As we discussed in the article, the
randomized controlled trial published by Hinchliffe et al3 found
similar mortality for rEVAR (53%) and OSR (53%). However,
there was signiﬁcant patient crossover from the rEVAR to the
OSR group, with intention-to-treat analysis. More than two-
thirds of the patients were excluded from the study because of
hemodynamic instability or staff unavailability.
We agree with Dr Dick and colleagues that EVAR suitability
would be expected to improve outcomes with rAAA repair, just
as elective open infrarenal AAA repair patients do better than
suprarenal. However, patients with infrarenal AAA undergoing
EVAR do better than with open surgery. This simply points out
that power calculations for randomized studies may have underes-
timated the number of subjects needed to show a difference.
We commend them on their excellent results. However, it is
possible that they may be able to improve their results even further
with a policy of using EVAR for ruptures. It may take longer to897
JOURNAL OF VASCULAR SURGERY
898 Letters to the Editor March 2013recognize the improvement, given their low mortality with open
repair. Unfortunately, most patients in the United States who
undergo surgery for rAAA do not beneﬁt from these odds of
survival.
The fact that overall mortality for rAAA has been reduced on
a population level in the United States,2 after the introduction and
expanded use of EVAR for rAAA, when there had been no change
for 2 decades previously4 suggests that EVARhasmade a difference.
If hemodynamically stable and anatomically simple patients were
selected for EVAR then the open mortality should have increased.
Although our series is small, it reﬂects a rapid improvement in
outcomes that we have been able to achieve that mirrors other
reports and is reﬂective of a national trend seen in the United States.
Not every clinical question needs a randomized controlled trial.
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Regarding “Patient outcomes and thoracic aortic
volume and morphologic changes following thoracic
endovascular aortic repair in patients with complicated
chronic type B aortic dissection”
We read with great interest the article by Andacheh et al.1
Despite a high perioperative mortality rate, the authors report
excellent 1-year results for endovascular treatment of patients
with complicated chronic type B dissection. Importantly, the
report outlines the degree of aortic remodeling after stent graft
treatment in this group of patients, showing expansion of the
true lumen and reduction of the false lumen in the thoracic aorta
over time. It is, however, not clear from the report if the positive
remodeling occurred in all patients or if there was a subgroup
with lack of remodeling and continued thoracic aortic expansion
requiring reintervention. Interestingly, in patients with aortic
dissection extending into the abdominal aorta, the abdominalaorta continued to expand. Although no deaths occurred from
rupture during the reported follow-up period of 18 months, this
remains a concern in the longer term.
In a recent report,2 we analyzed the outcome of 58 patients
treated with endovascular repair for chronic type B dissection at
St. Thomas’ Hospital. The rate of aortic remodeling was depen-
dent on the extent of the aortic dissection and the presence of false
lumen thrombosis. Although total false lumen thrombosis was
achieved in 83% of the patients with the dissection conﬁned to
the thoracic aorta, this was the case for only 23% of the patients
with dissection extending into the abdomen. Patients with less
than total false lumen thrombosis were more likely to experience
aortic expansion over time, which was the strongest predictor of
midterm mortality.
Aortic dissection is a diverse pathology with various patterns of
complications, anatomical extension, and chronic development.
The current literature clearly underlines the need for a tailored
therapeutic approach to this disease, based on the characteristics
of each patient and their pathology. For patients with aortic dissec-
tion extending into the abdomen, endovascular treatment of the
thoracic segment can be a ﬁrst step, but seems rarely to offer a ﬁnal
solution. Improved imaging techniques for assessment of false
lumen ﬂow and distal entry tears have the potential to further
guide the need for reintervention in these patients.3,4
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